e-learning
resources
Paris 2018
Monday, 17.09.2018
Challenges in tuberculosis care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Manifestations of hypersensitivity to anti-tuberculosis drugs
Y. BENBETKA (Algiers, Algeria), S. Souilah (Algiers, Algeria), A. Fissah (Algiers, Algeria)
Source:
International Congress 2018 – Challenges in tuberculosis care
Session:
Challenges in tuberculosis care
Session type:
Thematic Poster
Number:
2699
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. BENBETKA (Algiers, Algeria), S. Souilah (Algiers, Algeria), A. Fissah (Algiers, Algeria). Manifestations of hypersensitivity to anti-tuberculosis drugs. 2699
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Desensitization therapy for allergic reactions of antituberculous drugs
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Evaluation of antituberculous drugs administration
Source: Eur Respir J 2002; 20: Suppl. 38, 547s
Year: 2002
Immunoallergic manifestations of antituberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 505s
Year: 2006
Antituberculosis fixed multi-dose combination and single drug therapy in active tuberculosis: What is about drug hypersensitivity reactions?
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Hepatotoxicity due to antituberculosis drug treatment
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis II
Year: 2008
Anti-tuberculosis drugs
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017
Initial antituberculosis drugs resistance
Source: Eur Respir J 2006; 28: Suppl. 50, 12s
Year: 2006
Rapid oral desensitization to anti-tuberculosis drugs
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Monitoring of antituberculous drugs adverse events during the treatment of multidrug-resistant pulmonary tuberculosis
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Resistance to second-line anti-tuberculosis drugs: new drug resistant TB treatment problem
Source: Annual Congress 2007 - Drug-resistant and multidrug-resistant tuberculosis
Year: 2007
Predictors of hepatotoxicity among patients with tuberculosis treated with antituberculous medication
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Drug lymphocyte stimulation test in the diagnosis of adverse reactions to anti-tuberculosis drugs
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Severe adverse effects of antitubercular drugs and patient management
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Incidence and timing of hepatotoxicity due to anti-tuberculous treatment
Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions
Year: 2011
Adverse effects of second-line drugs during the treatment of multidrug resistant tuberculosis patients
Source: Eur Respir J 2005; 26: Suppl. 49, 650s
Year: 2005
Efficacy of intravenous administration of anti-tuberculosis drugs in patients with multidrug-resistant tuberculosis
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
Side-effect in the treatment of pulmonary tuberculosis by first-line drugs
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Outcomes of immunosuppressive therapy in chronic hypersensitivity pneumonitis
Source: ERJ Open Res, 3 (3) 00016-2017; 10.1183/23120541.00016-2017
Year: 2017
Management of adverse drug events in TB therapy
Source: Eur Respir Mon 2012; 58: 167-193
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept